Biomed Central Ltd

SHERPA: Unknown

People

  1. Schoenfeld
    Schoenfeld
  2. Chaft
    Chaft
  3. Gomez
    Gomez
  4. Bott
    Bott
  5. Brown
    Brown
  6. Chawla
    Chawla
  7. Chen
    Chen
  8. Crane
    Crane
  9. Cuaron
    Cuaron
  10. Falcon
    Falcon

Groups

  1. Department of Medicine (11)
  2. Hematologic Malignancies, Division of (11)
  3. Hematology-Oncology Fellows (11)
  4. Solid Tumor Oncology Division (11)
  5. Thoracic Oncology (11)
  6. Weinberg Fellows (11)
  7. Graduate Medical Education (5)
  8. GME, Medicine (4)
  9. Biostatistics Service (3)
  10. Epidemiology and Biostatistics (3)
Search Within
  1. "Adam Schoenfeld"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (4)
  3. Guidelines (1)
Groups
  1. Department of Medicine (11)
  2. Hematologic Malignancies, Division of (11)
  3. Hematology-Oncology Fellows (11)
  4. Solid Tumor Oncology Division (11)
  5. Thoracic Oncology (11)
  6. Weinberg Fellows (11)

More Groups

People
  1. Adam Schoenfeld (11)
  2. Arielle Elkrief (2)
  3. Daniel Gomez (2)
  4. Hira Rizvi (2)
  5. Jamie Chaft (2)
  6. Matthew Hellmann (2)

More People

Years
  1. 2025 (3)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (3)
  5. 2021 (2)
Publications
  1. Journal for ImmunoTherapy of Cancer (10)
  2. BMC Cancer (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
    Journal Article

    McMillan, M. T.; Reyngold, M.; Crane, C. H.; O'Brien, D. A. R.; Williams, V. M.; Zinovoy, M.; Cuaron, J. J.; Gönen, M.; Kaiser, A.; Sopka, D. M.; more...
    BMC Cancer (2025)

    Fulltext@MSK | Save
  • Allele-specific HLA LOH in solid tumors: Distinct patterns by tumor type and potential prognostic relevance
    Journal Article

    Sewastianik, T.; Roy, C.; Gormally, M.; Montesion, M.; Halvey, P.; Jindal, A.; Lam, H.; Schoenfeld, A.; Klebanoff, C. A.; Opiteck, G. J.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Journal Article

    Middha, P.; Thummalapalli, R.; Quandt, Z.; Balaratnam, K.; Cardenas, E.; Falcon, C. J.; Princess Margaret Lung Group; Gubens, M. A.; Huntsman, S.; Khan, K.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
    Guidelines

    Betof Warner, A.; Hamid, O.; Komanduri, K.; Amaria, R.; Butler, M. O.; Haanen, J.; Nikiforow, S.; Puzanov, I.; Sarnaik, A.; Bishop, M. R.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
    Journal Article

    Alessi, J. V.; Price, A.; Richards, A. L.; Ricciuti, B.; Wang, X.; Elkrief, A.; Pecci, F.; Di Federico, A.; Gandhi, M. M.; Lebow, E. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • A phase I study of personalized adoptive TCR T cell therapy in patients with solid tumors: Safety, efficacy, and T cell trafficking to tumors of non-virally gene edited T cells
    Meeting Abstract

    Foy, S.; Jacoby, K.; Bota, D.; Hunter, T.; Schoenfeld, A.; Pan, Z.; Stawiski, E.; Ma, Y.; Lu, W.; Peng, S. M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • A reproducible pipeline for analysis of multiplex imaging (MIBI) data with application to uncovering novel features of the tumorimmune microenvironment
    Meeting Abstract

    Maxey, J.; Thompson, M.; Campbell, K.; Kamphaus, B.; Bustami, Z.; Santulli-Marotto, S.; Wells, D.; Boffo, S.; Salvador, L.; Scumpia, P.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • ITIL-306-201: A multicenter, first-in-human phase 1a/1b study of ITIL-306, an engineered autologous tumor-infiltrating lymphocyte (TIL) cell therapy product, in adults with advanced solid tumor
    Meeting Abstract

    Ward, J.; Ghobadi, A.; Liao, J.; Schoenfeld, A.; Tykodi, S.; Jiang, Y.; Le Gall, J.; Alvarez-Rodriguez, R.; Sherman, M.; Singson, T.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • First phase 2 results of autologous tumor-infiltrating lymphocyte (TIL; LN-145) monotherapy in patients with advanced, immune checkpoint inhibitor-treated, non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Schoenfeld, A.; Lee, S.; Paz-Ares, L.; Doger, B.; Gettinger, S.; Haefliger, S.; Orcurto, A.; Sukari, A.; Papa, S.; Moreno, J. F. R.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save